New study examines use of reusable EHMRs

A team of researchers, led by Luis Ostrosky, MD, professor of infectious diseases and vice chair for Healthcare Quality, is seeking 100 UTHealth and Memorial Hermann-Texas Medical Center (TMC) healthcare workers to participate in a CDC-funded study. The study examines…


UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm

A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The clinical…


Pages